Since 1953, we've led the field with support for immunotherapy research and clinical trials. Together with our donor, patient, and scientist communities, we continue to fund revolutionary breakthroughs to cure all types of cancer.
By harnessing the innate powers of the body's immune system, immunotherapy treatments have the potential to achieve complete, long-lasting remissions and cures for all types of cancer. Immunotherapy is already saving lives, and while responses vary from patient to patient, with further research, we can bring more effective treatments to more cancer patients.
See how immunotherapy works
See Where Your Money Goes
Fundraise for immunotherapy
Share Stories and Connect
Become a corporate sponsor
Cancer Research Institute | National Headquarters 29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
Nivolumab (Opdivo®) is now available for patients with metastatic and treatment-resistant small cell lung cancer
Gloria Garcia was diagnosed in 2017 with small cell lung cancer. After combination ipilimumab/nivolumab immunotherapy treatment she went into remission.